FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306411832> ?p ?o ?g. }

• W4306411832 endingPage "423" @default.
• W4306411832 startingPage "414" @default.
• W4306411832 abstract "Rationale: Adult sepsis survivors have an increased risk of experiencing long-term cardiovascular events. Objectives: To determine whether the cardiovascular risk after sepsis is mitigated by renin-angiotensin system inhibitors (RASi). Methods: We conducted a population-based cohort study of adult sepsis survivors designed to emulate a target randomized trial with an active comparator and new-user design. We excluded patients with a first-line indication for prescription of RASi (e.g., coronary heart disease, heart failure, chronic kidney disease, and hypertension with diabetes mellitus). The main exposure of interest was a new prescription of a RASi within 30 days of hospital discharge. The active comparator was a new prescription of either a calcium channel blocker or a thiazide diuretic, also within 30 days of hospital discharge. The primary outcome of interest was the composite of myocardial infarction, stroke, and all-cause mortality during follow-up to 5 years. We used inverse probability weighting of a Cox proportional hazards model and reported results using hazard ratios with 95% confidence intervals. Results: The cohort included 7,174 adult sepsis survivors, of whom 3,805 were new users of a RASi and 3,369 were new users of a calcium channel blocker or a thiazide diuretic. New users of a RASi experienced a lower hazard of major cardiovascular events than new users of a calcium channel blocker or a thiazide diuretic (hazard ratio, 0.93; 95% confidence interval, 0.87-0.99). This association was consistent across different follow-up intervals and multiple sensitivity analyses. Conclusions: A new RASi prescription is associated with a reduction in major cardiovascular events after sepsis. A randomized controlled trial should be considered to confirm this finding." @default.
• W4306411832 created "2022-10-17" @default.
• W4306411832 creator A5011877915 @default.
• W4306411832 creator A5031981118 @default.
• W4306411832 creator A5034441524 @default.
• W4306411832 creator A5037944808 @default.
• W4306411832 creator A5050289436 @default.
• W4306411832 creator A5082294777 @default.
• W4306411832 creator A5090011318 @default.
• W4306411832 date "2023-03-01" @default.
• W4306411832 modified "2023-10-16" @default.
• W4306411832 title "Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis" @default.
• W4306411832 cites W180946569 @default.
• W4306411832 cites W1964098393 @default.
• W4306411832 cites W1967778685 @default.
• W4306411832 cites W1978209044 @default.
• W4306411832 cites W1980655557 @default.
• W4306411832 cites W2000445173 @default.
• W4306411832 cites W2008557562 @default.
• W4306411832 cites W2036193982 @default.
• W4306411832 cites W2054885815 @default.
• W4306411832 cites W2055606318 @default.
• W4306411832 cites W2091317254 @default.
• W4306411832 cites W2095754613 @default.
• W4306411832 cites W2113698123 @default.
• W4306411832 cites W2126125759 @default.
• W4306411832 cites W2138849500 @default.
• W4306411832 cites W2142495742 @default.
• W4306411832 cites W2152798629 @default.
• W4306411832 cites W2158860487 @default.
• W4306411832 cites W2261776294 @default.
• W4306411832 cites W2269838413 @default.
• W4306411832 cites W2275737843 @default.
• W4306411832 cites W2280404143 @default.
• W4306411832 cites W2298338128 @default.
• W4306411832 cites W2404984931 @default.
• W4306411832 cites W2511521172 @default.
• W4306411832 cites W2535326255 @default.
• W4306411832 cites W2735301415 @default.
• W4306411832 cites W2762747585 @default.
• W4306411832 cites W2782135811 @default.
• W4306411832 cites W2802214931 @default.
• W4306411832 cites W2803977650 @default.
• W4306411832 cites W2885504738 @default.
• W4306411832 cites W2891367027 @default.
• W4306411832 cites W2899235478 @default.
• W4306411832 cites W2900742318 @default.
• W4306411832 cites W2912388172 @default.
• W4306411832 cites W2921495327 @default.
• W4306411832 cites W2945495989 @default.
• W4306411832 cites W2947908105 @default.
• W4306411832 cites W2962931983 @default.
• W4306411832 cites W2998291663 @default.
• W4306411832 cites W2998853022 @default.
• W4306411832 cites W3092410836 @default.
• W4306411832 cites W3109906533 @default.
• W4306411832 cites W3164744083 @default.
• W4306411832 cites W3165459427 @default.
• W4306411832 cites W3192546440 @default.
• W4306411832 cites W3202672160 @default.
• W4306411832 cites W3214678152 @default.
• W4306411832 cites W3215487608 @default.
• W4306411832 cites W3217461162 @default.
• W4306411832 cites W4210991530 @default.
• W4306411832 cites W4226390647 @default.
• W4306411832 cites W4248253870 @default.
• W4306411832 doi "https://doi.org/10.1513/annalsats.202207-615oc" @default.
• W4306411832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36251422" @default.
• W4306411832 hasPublicationYear "2023" @default.
• W4306411832 type Work @default.
• W4306411832 citedByCount "2" @default.
• W4306411832 countsByYear W43064118322023 @default.
• W4306411832 crossrefType "journal-article" @default.
• W4306411832 hasAuthorship W4306411832A5011877915 @default.
• W4306411832 hasAuthorship W4306411832A5031981118 @default.
• W4306411832 hasAuthorship W4306411832A5034441524 @default.
• W4306411832 hasAuthorship W4306411832A5037944808 @default.
• W4306411832 hasAuthorship W4306411832A5050289436 @default.
• W4306411832 hasAuthorship W4306411832A5082294777 @default.
• W4306411832 hasAuthorship W4306411832A5090011318 @default.
• W4306411832 hasConcept C126322002 @default.
• W4306411832 hasConcept C127413603 @default.
• W4306411832 hasConcept C164705383 @default.
• W4306411832 hasConcept C207103383 @default.
• W4306411832 hasConcept C2778198053 @default.
• W4306411832 hasConcept C2779918671 @default.
• W4306411832 hasConcept C2780356492 @default.
• W4306411832 hasConcept C2780437262 @default.
• W4306411832 hasConcept C2780645631 @default.
• W4306411832 hasConcept C2908647359 @default.
• W4306411832 hasConcept C44249647 @default.
• W4306411832 hasConcept C71924100 @default.
• W4306411832 hasConcept C72563966 @default.
• W4306411832 hasConcept C78519656 @default.
• W4306411832 hasConcept C84393581 @default.
• W4306411832 hasConcept C99454951 @default.
• W4306411832 hasConceptScore W4306411832C126322002 @default.
• W4306411832 hasConceptScore W4306411832C127413603 @default.

• next